Related Experiment Videos
Hypertension and coronary heart disease risk factor management
1Vanderbilt University Medical Center, Nashville, TN.
Insights
Essential hypertension treatment should focus on preventing end-organ damage, not just lowering blood pressure. An individualized, pathophysiologic approach is recommended over traditional stepped care for better outcomes in hypertensive patients.
Area of Science:
- Cardiology
- Nephrology
- Neurology
Background:
- Essential hypertension increases risks for cerebrovascular, cardiovascular, and renal diseases.
- Current pharmacological treatments reduce some, but not all, hypertension-related complications.
- Atherosclerotic complications like coronary heart disease remain inadequately addressed by traditional therapies.
Purpose of the Study:
- To advocate for a shift from traditional stepped-care hypertension treatment to a more individualized, pathophysiologic approach.
- To emphasize reducing end-organ damage as the primary goal in managing essential hypertension.
- To highlight the need to consider the comprehensive impact of antihypertensive drugs on disease pathogenesis.
Main Methods:
- Proposed a new treatment paradigm based on eight parameters: pathophysiology, hemodynamics, end-organ damage, concomitant diseases, demographics, drug side effects and quality of life, compliance, and total healthcare costs.
- Critiqued the traditional stepped-care approach, which often prioritizes diuretics and beta-blockers.
- Defined hypertension as a syndrome encompassing multiple abnormalities beyond elevated blood pressure.
Main Results:
- Traditional therapy has improved outcomes for pressure-related damage (e.g., stroke, heart failure) but not atherosclerotic complications.
- A pathophysiologic and individualized approach is recommended for maximal reduction in morbidity and mortality.
- Hypertension is a complex syndrome involving dyslipidemia, insulin resistance, obesity, and other abnormalities.
Conclusions:
- Effective hypertension management requires a comprehensive strategy addressing the multifaceted nature of the syndrome.
- Individualized treatment plans considering multiple patient-specific factors are crucial for optimal outcomes.
- Reducing end-organ damage should be the central objective in essential hypertension therapy.
Abstract:
The primary goal in the treatment of essential hypertension is to reduce all end organ damage, not simply to reduce blood pressure. Hypertension is associated with an increased risk of cerebrovascular, cardiovascular and renal morbidity and mortality. Pharmacological therapy has reduced some, but not all, of these complications. In order to achieve maximal decrease in morbidity and mortality in hypertensive related diseases the overall impact of antihypertensive drug therapy on the pathogenesis of damage to each end organ must be considered. The pharmacological therapy of mild hypertension has reduced complications of most pressure related (arteriolar) damage such as cerebrovascular accidents, congestive heart failure, and some cases of chronic renal failure, but atherosclerotic complications, coronary heart disease, angina, myocardial infarction and sudden death have not been convincingly reduced. A more pathophysiologic and individualized approach to the treatment of hypertension is recommended in place of the traditional stepped care approach which has primarily emphasized diuretics and beta blockers as initial therapy. This new approach in the subsets of hypertension, which is based on eight parameters: (1) Pathophysiology; (2) Haemodynamics; (3) End organ damage; (4) Concomitant medical diseases and problems; (5) Demographics; (6) Adverse effects of drugs and quality of life; (7) Compliance with medication regimen; (8) Total health care costs: direct and indirect costs. Hypertension is not just a disorder of increased intraarterial pressure, but in fact, a syndrome of commonly associated genetic and/or acquired abnormalities including dyslipidaemia, insulin resistance, impaired glucose tolerance, central obesity, renal abnormalities, structural abnormalities of smooth muscle, and abnormal cellular cation transport or membranopathy.(ABSTRACT TRUNCATED AT 250 WORDS)